Storia in 1 fonti

Kanvas Biosciences raises $48 million to advance microbiome cancer therapies | Cornell Chronicle

Kanvas Biosciences announced a $48 million Series A funding round, which will support a clinical trial later this year for the company’s lead cancer immunotherapy treatment.

Raccontata da

duffield.cornell.edu

Timeline cronologica

lunedì 8 giugno 2026·duffield.cornell.edu
Kanvas Biosciences raises $48 million to advance microbiome cancer therapies | Cornell Chronicle
Kanvas Biosciences announced a $48 million Series A funding round, which will support a clinical trial later this year for the company’s lead cancer immunotherapy treatment.